These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6124899)

  • 1. Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
    Stahl SM; Berger PA
    Neurology; 1982 Aug; 32(8):889-92. PubMed ID: 6124899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia: treatment with bromocriptine.
    Newman RP; LeWitt PA; Shults C; Bruno G; Foster NL; Chase TN; Calne DB
    Clin Neuropharmacol; 1985; 8(4):328-33. PubMed ID: 3907823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic dystonia: neuropharmacological study.
    Girotti F; Scigliano G; Nardocci N; Angelini L; Broggi G; Giovannini P; Caraceni T
    J Neurol; 1982; 227(4):239-47. PubMed ID: 6183410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine, acetylcholine, and GABA effects in acute dystonia in primates.
    Casey DE; Gerlach J; Christensson E
    Psychopharmacology (Berl); 1980; 70(1):83-7. PubMed ID: 6775341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meige disease: striatal dopaminergic preponderance.
    Tolosa ES; Lai C
    Neurology; 1979 Aug; 29(8):1126-30. PubMed ID: 379689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromediator mechanisms of wakefulness and the voluntary behavior of cats].
    Shugalev NP; Adrianov OS; Iamshchikova NG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(5):861-8. PubMed ID: 2574928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisuride in dystonia.
    Quinn NP; Lang AE; Sheehy MP; Marsden CD
    Neurology; 1985 May; 35(5):766-9. PubMed ID: 3887215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
    Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
    Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Bromocriptine and spasmodic torticollis.
    Lees A; Shaw KM; Stern GM
    Br Med J; 1976 May; 1(6021):1343. PubMed ID: 773515
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine agonists in the treatment of dystonia.
    Lang AE
    Clin Neuropharmacol; 1985; 8(1):38-57. PubMed ID: 3884150
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment of dystonia.
    Pakkenberg H; Pedersen B
    Psychopharmacology Suppl; 1985; 2():111-7. PubMed ID: 2860654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.